Sapient Capital’s Gilead Sciences GILD Stock Holding History

Sapient Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.9M	Buy	165,115 +2,289	+1%	+$302K	0.27%	53
2026 Q1	$22.7M	Sell	162,826 -10,520	-6%	-$1.47M	0.34%	39
2025 Q4	$21.3M	Sell	173,346 -1,732	-1%	-$210K	0.3%	54
2025 Q3	$19.7M	Sell	175,078 -8,077	-4%	-$918K	0.3%	55
2025 Q2	$20.3M	Sell	183,155 -2,205	-1%	-$235K	0.36%	52
2025 Q1	$20.8M	Buy	185,360 +182,774	+7,068%	+$18.9M	0.41%	53
2024 Q4	$239K	Buy	2,586 +44	+2%	+$3.96K	﹤0.01%	338
2024 Q3	$213K	Buy	+2,542	New	+$194K	﹤0.01%	365
2024 Q1	–	Sell	-3,086	Closed	-$250K	–	378
2023 Q4	$250K	Buy	+3,086	New	+$240K	0.01%	332

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Sapient Capital's GILD Position: Q2 2026 in Review

Sapient Capital increased its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, buying an estimated $302K and bringing the position to 165,115 shares worth $20.9M. The position accounts for 0.27% of the portfolio, ranked #53.

Sapient Capital first reported a position in GILD in Q4 2023 and has held it in 9 quarters since. The position peaked at $22.7M in Q1 2026. 485 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Sapient Capital held 165,115 shares of Gilead Sciences worth $20.9M as of Q2 2026.
Sapient Capital bought 2,289 Gilead Sciences shares in Q2 2026, an estimated $302K.
Gilead Sciences made up 0.27% of Sapient Capital's portfolio in Q2 2026, its #53 holding.
Sapient Capital first reported a position in Gilead Sciences in Q4 2023 and has held it in 9 quarters since.
Sapient Capital's Gilead Sciences position peaked at $22.7M in Q1 2026.
485 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.